Notitia Biotechnologies Company
1 clinical trials · Sponsor
◉ Watch Notitia Biotechnologies Company
| Record | Firm | Date |
|---|---|---|
| NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients (NCT04540406) | Notitia Biotechnologies Company | 2021-11-02 |
Track Notitia Biotechnologies Company automatically
Every clearance here is in the API, with alerts when new ones post.